ES2390959T3 - Comprimidos de administración vaginal que contienen progesterona y procedimiento para preparar los mismos - Google Patents

Comprimidos de administración vaginal que contienen progesterona y procedimiento para preparar los mismos Download PDF

Info

Publication number
ES2390959T3
ES2390959T3 ES99972096T ES99972096T ES2390959T3 ES 2390959 T3 ES2390959 T3 ES 2390959T3 ES 99972096 T ES99972096 T ES 99972096T ES 99972096 T ES99972096 T ES 99972096T ES 2390959 T3 ES2390959 T3 ES 2390959T3
Authority
ES
Spain
Prior art keywords
progesterone
weight
tablet
vaginal administration
tablet according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99972096T
Other languages
English (en)
Spanish (es)
Inventor
Azariah Jossifoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Ferring BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring BV filed Critical Ferring BV
Application granted granted Critical
Publication of ES2390959T3 publication Critical patent/ES2390959T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES99972096T 1998-11-18 1999-11-17 Comprimidos de administración vaginal que contienen progesterona y procedimiento para preparar los mismos Expired - Lifetime ES2390959T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL12712998A IL127129A (en) 1998-11-18 1998-11-18 Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
IL12712998 1998-11-18
PCT/IL1999/000619 WO2000028970A1 (en) 1998-11-18 1999-11-17 Vaginally administrable progesterone-containing tablets and method for preparing same

Publications (1)

Publication Number Publication Date
ES2390959T3 true ES2390959T3 (es) 2012-11-20

Family

ID=11072154

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99972096T Expired - Lifetime ES2390959T3 (es) 1998-11-18 1999-11-17 Comprimidos de administración vaginal que contienen progesterona y procedimiento para preparar los mismos

Country Status (8)

Country Link
US (4) US7300664B1 (https=)
EP (2) EP1131052B1 (https=)
JP (2) JP4667601B2 (https=)
AU (1) AU1176200A (https=)
DK (1) DK1131052T3 (https=)
ES (1) ES2390959T3 (https=)
IL (1) IL127129A (https=)
WO (1) WO2000028970A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL127129A (en) * 1998-11-18 2004-06-01 Ferring Bv Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
FR2821555B1 (fr) * 2001-03-01 2003-05-16 Besins Int Lab Progestatif co-micronise avec un tensioactif, composition pharmaceutique le comprenant, leurs procedes de fabrication et leurs utilisations
ES2288641T3 (es) * 2002-12-20 2008-01-16 Dynogen Pharmaceuticals Inc. Metodo para tratar trastornos indoloros de la vejiga usando moduladores de canales del calcio de la subunidad alfa2-delta.
DE602004003172T2 (de) * 2003-03-21 2007-09-27 Dynogen Pharmaceuticals Inc., Waltham Verfahren zur behandlung von erkrankungen der unteren harnwege mit antimuskarinika und mit modulatoren der alpha-2-delta untereinheit des kalziumkanals
DE10316583A1 (de) 2003-04-10 2004-10-28 B.R.A.H.M.S Aktiengesellschaft Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung
US8828981B2 (en) * 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
CA2744906A1 (en) * 2007-11-29 2009-06-04 Gregg A. Jackson Progesterone-containing compositions and devices
US9107696B2 (en) * 2008-08-06 2015-08-18 Emory University Method of embryo transfer that eliminates transferred air while hormonally inducing implantation and apparatus
WO2011073995A2 (en) 2009-12-14 2011-06-23 Lincoln Pharmaceuticals Limited Liquid vaginal spray of progesterone
FR2997627B1 (fr) * 2012-11-08 2015-01-16 Hra Pharma Lab Produit de co-micronisation comprenant de l'ulipristal acetate
CN114129530A (zh) * 2021-12-08 2022-03-04 南京康川济医药科技有限公司 一种黄体酮缓释组合物及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121663A (en) 1956-02-09 1964-02-18 Plough Lab Inc Carbon dioxide releasing laxative suppository
US4310510A (en) * 1976-12-27 1982-01-12 Sherman Kenneth N Self administrable anti-fertility composition
US4252787A (en) * 1976-12-27 1981-02-24 Cambridge Research And Development Group Anti-fertility composition and method
US4187286A (en) * 1979-01-02 1980-02-05 G&W Laboratories, Inc. Contraceptive suppository
US4322399A (en) * 1979-10-19 1982-03-30 Ortho Pharmaceutical Corporation Vaginal suppository
JPS58152809A (ja) * 1982-03-05 1983-09-10 Eisai Co Ltd 安定な発泡性「膣」坐剤
US4583211A (en) * 1982-06-15 1986-04-15 Tokyo Shibaura Denki Kabushiki Kaisha Frequency detecting circuit for digital information reproducing system
JPS6165822A (ja) * 1984-09-06 1986-04-04 Kao Corp 月経困難症治療用膣投与剤
US5084277A (en) 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
US5116619A (en) * 1988-08-30 1992-05-26 Lee Roy Morgan Vaginal progesterone tablet
DK95093D0 (da) * 1993-08-20 1993-08-20 Novo Nordisk As Farmaceutisk formulering indeholdende et hormon
US5543150A (en) 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
CH689802A5 (de) * 1995-01-16 1999-11-30 Grapha Holding Ag Einrichtung zur Vereinzelung von stapelweise zugeführten flachen Gegenständen.
US5804277A (en) * 1995-11-30 1998-09-08 The United States Of America As Represented By The Secretary Of The Air Force Three-dimensional fiber weave with cubic symmetry and no zero valued shear moduli
US5958455A (en) * 1996-02-09 1999-09-28 Quadrant Holdings Cambridge Ltd Oral solid dosage forms, methods of making same and compositions thereof
US5837861A (en) * 1997-02-10 1998-11-17 Inspire Pharmaceuticals, Inc. Dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency
US6096291A (en) * 1996-12-27 2000-08-01 Biovector Therapeutics, S.A. Mucosal administration of substances to mammals
US5993856A (en) 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
US6306914B1 (en) * 1997-10-21 2001-10-23 Columbia Laboratories, Inc. Progestin therapy for maintaining amenorrhea
NZ330596A (en) * 1998-06-05 2001-02-23 Dec Res Intravaginal devices allowing for increased uptake of active ingredients
FR2772617B1 (fr) 1997-12-19 2001-03-09 Besins Iscovesco Lab Comprime de progesterone et son procede de preparation
FR2777784B1 (fr) * 1998-04-27 2004-03-19 Arepa Composition pharmaceutique a base d'estrogene et de progesterone
IL127129A (en) * 1998-11-18 2004-06-01 Ferring Bv Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
US20070178139A1 (en) * 1998-11-18 2007-08-02 Yankov Vladimir I Vaginally administratable progesterone-containing tablets and method for preparing same
DE102012021570A1 (de) * 2012-11-02 2014-05-22 Merck Patent Gmbh Eu-aktivierte Leuchtstoffe

Also Published As

Publication number Publication date
EP1131052A1 (en) 2001-09-12
JP2011026335A (ja) 2011-02-10
IL127129A (en) 2004-06-01
WO2000028970A1 (en) 2000-05-25
JP4667601B2 (ja) 2011-04-13
IL127129A0 (en) 1999-09-22
EP1131052A4 (en) 2009-04-01
DK1131052T3 (da) 2012-10-15
US7300664B1 (en) 2007-11-27
US20050008694A1 (en) 2005-01-13
JP2002529494A (ja) 2002-09-10
US7393543B2 (en) 2008-07-01
AU1176200A (en) 2000-06-05
EP2386291A1 (en) 2011-11-16
US20060188571A1 (en) 2006-08-24
US20050181045A1 (en) 2005-08-18
EP1131052B1 (en) 2012-07-11
US7320800B2 (en) 2008-01-22

Similar Documents

Publication Publication Date Title
Levy et al. Pharmacokinetics of the progesterone-containing vaginal tablet and its use in assisted reproduction
US8247393B2 (en) Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
JP2011026335A (ja) プロゲステロン含有経膣投与用錠剤およびその調製法
US10821118B2 (en) Oral transmucosal drug delivery system
ES2877186T3 (es) Comprimido orodispersable que contiene estetrol
ES2671160T3 (es) Unidad de dosificación orodispersable que contiene un componente estetrol
US20070178139A1 (en) Vaginally administratable progesterone-containing tablets and method for preparing same
TWI239249B (en) Vaginally administrable progesterone-containing tablets and method for preparing same
CA2568823C (en) Vaginally administrable progesterone-containing tablets and method for preparing same
JPS63310817A (ja) 徐放性バッカル剤の製法
CN111529491A (zh) 一种速效安全的替格瑞洛口腔喷雾剂及其制备方法
HK1150532A (en) Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
OA18501A (en) Orodispersible dosage unit containing an estetrol component.
HK1215529B (en) Oral transmucosal drug delivery system